Treatment Landscape in HR+, HER2- MBC
ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNOTE-756 & BEGONIA"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Paolo Tarantino
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Paolo Tarantino
Login to view comments.
Click here to Login
Treatment Landscape in HR+, HER2- MBC